首页> 外文期刊>Hematological oncology >Intensive induction chemotherapy vs vs hypomethylating agent–based regimen in patients aged ≥70?years with newly diagnosed acute myeloid leukemia
【24h】

Intensive induction chemotherapy vs vs hypomethylating agent–based regimen in patients aged ≥70?years with newly diagnosed acute myeloid leukemia

机译:在≥70岁≥70岁的患者中,强化诱导化疗与基于低甲基化剂的方案,新诊断术急性髓性白血病

获取原文
获取原文并翻译 | 示例
           

著录项

  • 来源
    《Hematological oncology》 |2018年第2期|共3页
  • 作者单位

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

    Mario Lemieux Center for Blood CancersUniversity of Pittsburgh Medical CenterPittsburgh PA USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    AML; hypomethylating agent; intensive chemotherapy;

    机译:AML;低甲基化剂;密集化疗;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号